Coronary interventions

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study

EuroIntervention 2015;11:926-934 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_12

Martin Unverdorben
Martin Unverdorben1, MD, PhD; Christian Vallbracht2, MD; Bodo Cremers3, MD; Hubertus Heuer4, MD; Christian Hengstenberg5, MD; Christian Maikowski6, MD; Gerald S. Werner7, MD; Diethmar Antoni8, MD; Franz X. Kleber9, MD; Wolfgang Bocksch10, MD; Matthias Leschke11, MD; Hanns Ackermann12, MD; Michael Boxberger13, PhD; Ulrich Speck14, PhD; Ralf Degenhardt1*, PhD; Bruno Scheller3, MD
1. Institut für Klinische Forschung, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Germany; 2. Kardiologische Klinik, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Germany; 3. Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes,

Aims: Treatment of bare metal in-stent restenosis with the paclitaxel-coated balloon catheter based on the PACCOCATH® technology has yielded superior six-mon

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

drug-coated balloonlong-tern follow-uppaclitaxel
Read next article
Severe consequences of high-dose radiation

Latest news